Top Markets
Coin of the day
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
Rang in Aktien #20222
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Aktienkurs
$1.91
Marktkapitalisierung
$136.47M
Veränderung (1 Tag)
-1.15%
Veränderung (1 Jahr)
21.17%
Land
TW
Handel Sinew Pharma Inc. (6634)

Kategorie

Aktien-Split-Historie für Sinew Pharma Inc. (6634)
Die Aktie Sinew Pharma Inc. (Symbol: 6634) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 24, 2026 statt.
Eine 6634-Aktie, die vor dem Aug 24, 2026 gekauft wurde, entspricht heute 0 6634-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US